Sterling Pharma Acquires NewChem Technologies
Sterling Pharma Completes Acquisition of Novartis API Mfg. Facility
Sterling Pharma Solutions will join a consortium of leading industrial innovators from across the chemical industry supply chain to accelerate the use of continuous manufacturing in a range of industries, with digitalization at its core.
Global Healthcare Opportunities, or GHO Capital Partners LLP, a European specialist investor in global healthcare, and Partners Group, a global private markets firm, acting on behalf of its clients, has invested in GHO portfolio company Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO).
Sterling supports True Colours Theatre
Sterling wins at Made in the North East annual awards
The UK-based contract manufacturer Sterling Pharma Solutions has completed a purchase that will give it a manufacturing presence on the other side of the Irish Sea.
Sterling wins Manufacturing Award at North East Business Awards 2022
Sterling’s CEO Nominated as Top 10 Leader in Small Molecules
Sterling Pharma Solutions, a global contract development and manufacturing organization (CDMO), announced a £1 million expansion project at its Deeside, UK site, which is the company’s dedicated bioconjugation and antibody-drug conjugates (ADCs) facility. The project will increase the current laboratory space from 275 to 419 square meters, and reconfigure the layout to provide the ability to develop and expand areas in the future for additional services.